Are you an immunizing pharmacist or student pharmacist looking for current information pertaining to immunization schedules, newly licensed vaccines, and emerging vaccine technologies? The speaker for this archived webinar is APhA’s liaison member to the ACIP and presented the latest information from the October 23-24, 2019 ACIP Meeting held in Atlanta, Georgia.
Pharmacists are encouraged to enroll in this archived education event to stay abreast of recent immunization recommendations that may have a significant impact on your practice and continuing education.
At the completion of this knowledge-based activity, pharmacists will be able to:
- Identify how recent ACIP recommended changes may impact pharmacy practice.
- Explain the reasons the ACIP recommendation was made, including changes in epidemiology of disease, data from clinical trials, newly available vaccines, or safety issues discovered.
- Discuss newly available information regarding existing and emerging vaccines, shortages and availability of vaccines, safety concerns, and outbreaks of vaccine preventable diseases.
Activity type: Knowledge-based
Target Audience: Pharmacists & Pharmacy Technicians
Learning Level: 2
The American Pharmacists Association is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. The following archived webinar is approved for 1.0 contact hour of CPE credit (0.1 CEUs). The ACPE Universal Activity Numbers for this activity are 0202-0000-19-288-H06-P/T.
To obtain credit for completing October 2019 ACIP Immunization Update (Home Study), participants will need to watch the archived webinar, complete the assessment with a grade of 70% or better, complete the evaluation questions, and then CLAIM credit. Participants need to have a valid pharmacist.com username and password to claim credit. After credit has been claimed, please visit CPE monitor for your transcript.
Initial release date: November 7, 2019
Expiration date: November 7, 2022
October 2019 ACIP Immunization Update (Home Study) is an activity for pharmacists and pharmacy technicians developed by the American Pharmacists Association.
Stephan L. Foster, PharmD, FAPhA, declares receiving honoraria as a speaker for the following organizations: Pfizer, Seqirus, Merck Vaccine, and Sanofi-Pasteur. Dr. Foster also declares receiving honoraria as an Advisory Board member for Pfizer.
APhA’s editorial staff declares no conflicts of interest or financial interests in any product or service mentioned in this activity, including grants, employment, gifts, stock holdings, and honoraria. For a complete list of APhA staff disclosures, visit the APhA website at www.pharmacist.com/apha-disclosures.
Conflicts of interest have been resolved through content review by Helen Sairany, BA, PharmD, MBA, BCACP, Director of Content Development & Partnership at the American Pharmacists Association.
There is no fee associated with this activity. This CPE-accredited activity is open to APhA members and nonmembers.
Computer and internet access are required to complete this activity. Please visit our website to view the Technology System Requirements in order to have a positive learning experience.
|Activity Number||Credit Amount||Accreditation Period|
|ACPE# 0202-0000-19-288-H06-P||0.1 CEUs||November 07, 2019 - November 07, 2022|
|ACPE# 0202-0000-19-288-H06-T||0.1 CEUs||November 07, 2019 - November 07, 2022|